CFD Research awarded FDA grant to study bioequivalence of ophthalmic drug products
CFD Research was recently awarded a $400k research grant addressing the critical need for the development of computational tools to translate preclinical testing results from animals to humans for ophthalmic drug products. This project will provide researchers with a better understanding of the specific differences between animal and human eyes that result in differences in ocular drug distribution.